Company profile

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

6990 · HKEX

Public Market Listing

6990HKEX

HKEX primary exchange listing

Live quotes, historical charts, and market capitalization for Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(4 total)
4Total Assets
0Approved
0Phase 3 / Filed
4Phase 1–2 / Early
3Diseases
Quick filter:
Showing 4 of 4 assets
Target & Modality
KL-A167
Phase 2
PD-L1Small molecule
Non-Small Cell Lung CancerHR+/HER2- Breast Cancer
HR+/HER2- Metastatic Breast Cancer
KL590586
Phase 2
RETSmall molecule
Non-Small Cell Lung Cancer
SKB571 For
Phase 2
EGFR x c-METAntibody–drug conjugate
Non-Small Cell Lung Cancer
SKB575
Phase 1
Undisclosed / early pipelineMultispecific antibody
Asthma

Upcoming events

Research

Unlock the company readout calendar

Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.

Financial reports

Research

Unlock sourced financial history

Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.

Educational data tool. Figures are sourced from company filings and press releases: see each row's filing link. Share price is delayed (~15min) and refreshed periodically, not a real-time feed.